Company Filing History:
8 out of 2,078 
3 out of 77 Years Active: 2006-2013
Title: The Innovative Contributions of Heather Rae Hufnagel
Introduction
Heather Rae Hufnagel is a prominent inventor based in Glenmoore, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 11 patents to her name, Hufnagel's work has the potential to impact the treatment of serious diseases.
Latest Patents
Among her latest patents are two notable inventions. The first is titled "4-Azetidinyl-1-phenyl-cyclohexane antagonists of CCR2." This invention comprises compounds of Formula (I), which are designed to prevent, treat, or ameliorate conditions such as type II diabetes, obesity, and asthma. The method involves inhibiting CCR2 activity in mammals through the administration of a therapeutically effective amount of the compounds. The second patent is "4-azetidinyl-1-heteroaryl-cyclohexanol antagonists of CCR2." Similar to the first, this invention includes pharmaceutical compositions that aim to address CCR2 mediated syndromes, disorders, or diseases.
Career Highlights
Hufnagel has worked with reputable companies in the pharmaceutical industry, including Janssen Pharmaceutica NV and 3-Dimensional Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in drug development and innovation.
Collaborations
Throughout her career, Hufnagel has collaborated with notable professionals in her field, including Ehab Khalil and Kristi A. Leonard. These collaborations have likely enhanced her research and development efforts.
Conclusion
Heather Rae Hufnagel's innovative work in pharmaceuticals demonstrates her commitment to advancing medical science. Her patents reflect her dedication to finding solutions for complex health issues.